US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long NVO ETF

12.08

+0.48004.14%

Volume:46.97K

Turnover:559.32K

Market Cap:31.63M

PE:- -

High:12.09

Open:11.74

Low:11.74

Close:11.60

52wk High:36.00

52wk Low:9.23

Shares:2.62M

Float Shares:2.62M

Volume Ratio:3.08

T/O Rate:1.79%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

After Ozempic, Novo Nordisk Bets On Anthropic—While Pharma Still Awaits AI's First Approved Drug

Bellwether Stocks Movement

Novo Nordisk announces FRONTIER5 Phase 3b results for denecimig

Novo, Orbis Sign up to $1.4 Billion Deal to Develop Oral Drugs

Sector Update: Healthcare

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/NVOX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVOX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOX\",,,,,undefined,":{"symbol":"NVOX","market":"US","secType":"STK","nameCN":"Defiance Daily Target 2X Long NVO ETF","latestPrice":12.08,"timestamp":1789653048893,"preClose":11.6,"halted":0,"volume":46972,"delay":0,"changeRate":0.04137931034482763,"floatShares":2618100,"shares":2618100,"eps":0,"marketStatus":"Trading","change":0.48,"latestTime":"09-17 09:50:59 EDT","open":11.74,"high":12.085,"low":11.74,"amount":559324.397836,"amplitude":0.029741,"askPrice":12.09,"askSize":100,"bidPrice":12.08,"bidSize":300,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789675200000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":11.6,"sharesOutstanding":4098101,"nav":12.06,"aum":31574298.06,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":11.776,"preClose":11.6,"latestTime":"09:26 EDT","volume":7827,"amount":91568.871354,"timestamp":1789651593775,"change":0.176,"changeRate":0.015172,"amplitude":0.016672},"postHourTrading":{"tag":"盘后","latestPrice":11.65,"preClose":11.6,"latestTime":"19:30 EDT","volume":4001,"amount":46547.819,"timestamp":1789601404564,"change":0.05,"changeRate":0.00431,"amplitude":0.008509},"volumeRatio":3.080595,"impliedVol":0.6859,"impliedVolPercentile":0.232},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOX\",,,,,undefined,":{"symbol":"NVOX","floatShares":2618100,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":3.080595,"shares":2618100,"dividePrice":0,"high":12.085,"amplitude":0.029741,"preClose":11.6,"low":11.74,"week52Low":9.23,"pbRate":"--","week52High":36,"institutionHeld":0,"latestPrice":12.08,"committee":0.5,"eps":0,"divideRate":0,"volume":46972,"delay":0,"ttmEps":0,"open":11.74,"prevYearClose":21.89,"prevWeekClose":12.39,"prevMonthClose":13.84,"prevQuarterClose":16.05,"fiveDayClose":12.98,"twentyDayClose":14.64,"sixtyDayClose":15.76},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-12-09","symbol":"NVOX","defaultRemindTime":1765290600000,"type":"split","dateTimestamp":1765256400000,"forFactor":8,"toFactor":1,"ratio":8}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1187855436","title":"After Ozempic, Novo Nordisk Bets On Anthropic—While Pharma Still Awaits AI's First Approved Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1187855436","media":"Bellwether Stocks Movement","labels":[],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1187855436?lang=en_us&edition=fundamental","pubTime":"2026-09-17 08:57","pubTimestamp":1789606620,"startTime":"0","endTime":"0","summary":"","market":"fut","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/1859.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/1859.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"After Ozempic, Novo Nordisk Bets On Anthropic—While Pharma Still Awaits AI's First Approved Drug","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","NVOX","NVO","NVOC"],"isVideo":true,"video":{"duration":215,"video_url":"https://news-video-sg.skytigris.cn/videos/remotion/1859/render_1859_1789604974170.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/1859.webp","audio_url":"https://news-video-sg.skytigris.cn/videos/remotion/1859/tts/voiceover_37462307a3628b11.mp3","isAI":true},"gpt_icon":0},{"id":"2668961347","title":"Novo Nordisk announces FRONTIER5 Phase 3b results for denecimig","url":"https://stock-news.laohu8.com/highlight/detail?id=2668961347","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668961347?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:20","pubTimestamp":1789644013,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) ‘announced that phase 3b results from the FRONTIER5 study of investigational denecimig were published in the Journal of Thrombos...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-announces-frontier5-phase-3b-results-for-denecimig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-announces-frontier5-phase-3b-results-for-denecimig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVOX","NVO","LU0154236417.USD","BK4585","IE00BZ1G4Q59.USD","LU1093756168.USD","PPH","BK4599","IE00BKVL7J92.USD","BK4588","OZEM","LU1093756325.SGD","NVOH","NVOC","BK4532","THNR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668969658","title":"Novo, Orbis Sign up to $1.4 Billion Deal to Develop Oral Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2668969658","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668969658?lang=en_us&edition=fundamental","pubTime":"2026-09-17 19:00","pubTimestamp":1789642800,"startTime":"0","endTime":"0","summary":"Novo, Orbis sign up to $1.4 billion deal to develop oral drugsSept 17 (Reuters)-Orbis Medicines said on Thursday it had signed a drug discovery and licensing deal with Novo NordiskNOVOb.COworth up to ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nL4N45817K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4599","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4532","LU0154236417.USD","NVO","PPH","LU1093756168.USD","IE00BKVL7J92.USD","BK4585","OZEM","THNR","BK4007","NVOC","NVOH","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668938436","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2668938436","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668938436?lang=en_us&edition=fundamental","pubTime":"2026-09-17 03:13","pubTimestamp":1789586017,"startTime":"0","endTime":"0","summary":"Healthcare stocks were mixed late Wednesday afternoon, with the NYSE Healthcare Index fractionally lower and the State Street Health Care Select Sector SPDR ETF  up 0.1%.The iShares Biotechnology ETF  was 0.2% lower.In corporate news, Novo Nordisk  is collaborating with AI firm Anthropic to try to address key drug discovery challenges, develop targeted solutions and accelerate the development of new medicines, the companies said Wednesday. Novo shares were down 2.1%.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4599","NVO","BK4007","BK4585","LU0154236417.USD","LU1093756325.SGD","THNR","OZEM","BK4588","PPH","NVOH","NVOX","IE00BZ1G4Q59.USD","NVOC","BK4532","IE00BKVL7J92.USD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NVOX\",params:#limit:6,delay:false,,,undefined,":[]}}